In this issue:
Sofosbuvir/velpatasvir/voxilaprevir for HCV
Increased risk of CKD in chronic HCV
Glecaprevir/pibrentasvir in HCV genotype 2
Glecaprevir/pibrentasvir for HCV genotype 3
HCV testing in persons born during 1945-1965
HLA variants and risk of HCC modified by HCV genotypes
Serum HBV-RNA levels and intrahepatic activity markers
HCV eradication and risk of HCC
Ravidasvir + sofosbuvir for chronic HCV genotype 4
Durability of HBV surface antigen seroclearance
Please login below to download this issue (PDF)